Publications by authors named "Kevin R Imrie"

Claim this Profile
M
Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with Y ibritumomab tiuxetan in a phase II study.
Neil L Berinstein, Nancy M Pennell, Rashmi Weerasinghe, Rena Buckstein, Eugenia Piliotis, Kevin R Imrie

Hematol Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resident duty hours: past, present, and future.
Kevin R Imrie, Jason R Frank, Christopher S Parshuram

BMC Med Educ· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12.
Matthew C Cheung, Annette E Hay, Michael Crump, Kevin R Imrie, Yuyao Song

J Natl Cancer Inst· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.
Michael Crump, John Kuruvilla, Stephen Couban, David A MacDonald, Vishal Kukreti, Kevin R Imrie

J Clin Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Hany R Guirguis, Matthew C Cheung, Mervat Mahrous, Eugenia Piliotis, Neil Berinstein, Kevin R Imrie

Br J Haematol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma.
Lauren M Gerard, Kevin R Imrie, Joy Mangel, Rena Buckstein, Mary Doherty

Leuk Lymphoma· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of follicular (FL) and other indolent non-Hodgkin's lymphomas (NHL) on work productivity-a preliminary analysis.
Matthew C Cheung, Kevin R Imrie, Jessica Friedlich, Rena Buckstein, Nina Lathia

Psychooncology· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the follicular lymphoma microenvironment - ready for prime-time?
Matthew C Cheung, Kevin R Imrie

Leuk Lymphoma· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma.
Matthew C Cheung, Kevin R Imrie, Heather A Leitch, Laura Y Park-Wyllie, Rena Buckstein

Ann Hematol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario.
Matthew C Cheung, Adam E Haynes, Ralph M Meyer, Adrienne Stevens, Kevin R Imrie

Cancer Treat Rev· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkin's lymphoma.
Kevin R Imrie, David C Linch, Myron S Czuczman

Anticancer Drugs· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis